BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19836370)

  • 41. Inflammation in transgenic mouse models of neurodegenerative disorders.
    Schwab C; Klegeris A; McGeer PL
    Biochim Biophys Acta; 2010 Oct; 1802(10):889-902. PubMed ID: 19883753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Considering a new paradigm for Alzheimer's disease research.
    Langley GR
    Drug Discov Today; 2014 Aug; 19(8):1114-24. PubMed ID: 24662035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Current state of Alzheimer's disease models: a brief overview].
    Michikawa M
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():233-40. PubMed ID: 22787788
    [No Abstract]   [Full Text] [Related]  

  • 44. Novel approaches to models of Alzheimer's disease pathology for drug screening and development.
    Shaughnessy L; Chamblin B; McMahon L; Nair A; Thomas MB; Wakefield J; Koentgen F; Ramabhadran R
    J Mol Neurosci; 2004; 24(1):23-32. PubMed ID: 15314246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A comprehensive form for the standardized characterization of transgenic rodents: genotype, phenotype, welfare assessment, recommendations for refinement].
    Mertens C; Rülicke T
    ALTEX; 2000; 17(1):15-21. PubMed ID: 11103109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutant mice: experimental organisms as materialised models in biomedicine.
    Huber L; Keuck LK
    Stud Hist Philos Biol Biomed Sci; 2013 Sep; 44(3):385-91. PubMed ID: 23545252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgenic model applications to drug discovery.
    Polites HG
    Int J Exp Pathol; 1996 Dec; 77(6):257-62. PubMed ID: 9155659
    [No Abstract]   [Full Text] [Related]  

  • 48. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
    Windisch M
    Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Animal models of Alzheimer's disease and drug development.
    Laurijssens B; Aujard F; Rahman A
    Drug Discov Today Technol; 2013 Sep; 10(3):e319-27. PubMed ID: 24050129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Animal models in the drug discovery pipeline for Alzheimer's disease.
    Van Dam D; De Deyn PP
    Br J Pharmacol; 2011 Oct; 164(4):1285-300. PubMed ID: 21371009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Species-Specific Genetics on Alzheimer's Mouse Models.
    Hyman B; Tanzi RE
    Neuron; 2019 Feb; 101(3):351-352. PubMed ID: 30731053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zebrafish as a tool in Alzheimer's disease research.
    Newman M; Verdile G; Martins RN; Lardelli M
    Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How efficient are rodent models for Alzheimer's disease drug discovery?
    Guo B; Zhou Q
    Expert Opin Drug Discov; 2018 Feb; 13(2):113-115. PubMed ID: 29082769
    [No Abstract]   [Full Text] [Related]  

  • 54. Metabolism of a potent neuroprotective hydrazide.
    Chiruta C; Zhao Y; Tang F; Wang T; Schubert D
    Bioorg Med Chem; 2013 May; 21(10):2733-41. PubMed ID: 23582448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First International Conference on Unconventional Animal Models of Alzheimer's Disease and Aging.
    Cogram P; Garduño BM; Ren B; Xu X
    J Alzheimers Dis; 2024; 98(1):333-336. PubMed ID: 38393919
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease.
    Balmus IM; Ciobica A; Negura A; Negura L; Anton E
    Psychiatr Danub; 2015 Dec; 27(4):338-45. PubMed ID: 26609645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's drug pipeline is robust, and usage is quickly expanding.
    Sipkoff M
    Manag Care; 2009 Jun; 18(6):31-2. PubMed ID: 19569568
    [No Abstract]   [Full Text] [Related]  

  • 58. What is the gold standard model for Alzheimer's disease drug discovery and development?
    Cacabelos R; Carrera I; Martínez-Iglesias O; Cacabelos N; Naidoo V
    Expert Opin Drug Discov; 2021 Dec; 16(12):1415-1440. PubMed ID: 34330186
    [No Abstract]   [Full Text] [Related]  

  • 59. Progress in the modeling of neurodegenerative diseases in transgenic mice.
    Duff K; Rao MV
    Curr Opin Neurol; 2001 Aug; 14(4):441-7. PubMed ID: 11470959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How does a researcher choose the best rodent model for their Alzheimer's disease drug discovery study?
    Van Dam D; De Deyn PP
    Expert Opin Drug Discov; 2020 Mar; 15(3):269-271. PubMed ID: 31592694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.